The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer
Open Access
- 1 December 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 12 (12), 1671-1675
- https://doi.org/10.1023/a:1013582618920
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of LifeJournal of Clinical Oncology, 1999
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- A Consumer's Guide to Subgroup AnalysesAnnals of Internal Medicine, 1992
- Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.Journal of Clinical Oncology, 1991
- A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung CancerNew England Journal of Medicine, 1990
- SUBGROUP ANALYSISThe Lancet, 1988